Dawen Bu
Neurology · Prince George, VANPI 1710154786
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,663 and has fallen 91.9% since, to $134 in 2021.
Across 179 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$534
- Novartis$342
- UCB, Inc.$268
- Biogen$232
- Lundbeck LLC$177
- Sunovion Pharmaceuticals Inc.$167
- plus $2K from 30 others
What the payments were for
- Speaking & faculty fees$130%
- Food & beverage$3,316100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 16 | $534 |
| Novartis | 19 | $342 |
| UCB, Inc. | 16 | $268 |
| Biogen | 15 | $232 |
| Lundbeck LLC | 12 | $177 |
| Sunovion Pharmaceuticals Inc. | 8 | $167 |
| EMD Serono, Inc. | 10 | $167 |
| CSL Behring | 7 | $125 |
| Eisai Inc. | 7 | $123 |
| AbbVie(2 entities) | 7 | $116 |
| Sanofi | 5 | $98 |
| Neurocrine Biosciences, Inc. | 5 | $96 |
| Genentech USA, Inc. | 5 | $92 |
| AstraZeneca | 4 | $88 |
| Livanova USA, Inc. | 5 | $84 |
| Amgen | 4 | $76 |
| Currax Pharmaceuticals LLC | 4 | $61 |
| Amneal Pharmaceuticals LLC | 4 | $52 |
| Pfizer | 3 | $43 |
| Avanir Pharmaceuticals, Inc. | 3 | $41 |
| Mallinckrodt Hospital Products Inc. | 2 | $36 |
| Promius Pharma LLC | 2 | $32 |
| Tanabe Pharma America, Inc. | 1 | $30 |
| Biohaven Pharmaceuticals, Inc. | 1 | $27 |
| Neurelis, Inc. | 2 | $25 |
| Bristol Myers Squibb | 1 | $23 |
| Lilly USA, LLC | 2 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Upsher-smith Laboratories LLC | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Grifols USA, LLC | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $15 |
| MDD US Operations, LLC | 1 | $13 |
| Acorda Therapeutics, Inc | 1 | $13 |
How this compares
$3,329 in reported general payments places this provider in the 60th percentile of 474 neurology providers in Virginia.
Other neurology in Prince George
- Ramsey FalconerAlexandria$2M
- Robert ShinCharlottesville$1.7M
- Heidi CraytonVienna$1.5M
- Mark LandrioWinchester$631K
- Catherine HamRichmond$603K
- Jill CramerChristiansburg$598K
- Rahul DaveFairfax$540K
- Daniel HardyRichmond$382K
- Ingrid Loma MillerNorfolk$364K
- Carmen FuentesNorfolk$339K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.